title: Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma.
authors: Department of Medicine, Division of Hematology/Oncology, Mt Sinai School of Medicine, New York, NY 10029, USA. ajai.chari@mssm.edu
authors: Ajai
authors: A
authors: Chari
authors: Hadass
authors: H
authors: Pri-Chen
authors: Sundar
authors: S
authors: Jagannath
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction
chemical_list: D000911:Antibodies, Monoclonal; C504234:siltuximab